Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Profit After Tax (2016 - 2024)

Immuron (IMRN) posted quarterly Profit After Tax of $1660259165.7 billion for Q4 2024, up 80082653894883.1% year-over-year from N/an in Q1 2024, and up 80082653894883.1% quarter-over-quarter from -$2.1 million in Q4 2023.

Immuron (IMRN) Profit After Tax (2016 - 2024) Analysis & Trends

Immuron's Profit After Tax history runs 9 years deep, the most recent figure standing at $1660259165.7 billion for Q4 2024.

  • In Q4 2024, Profit After Tax rose 80082653894883.1% year-over-year to $1660259165.7 billion; the TTM figure through Dec 2024 stood at $1660259165.7 billion (up 38776595225883.33% YoY), while the FY2025 annual figure was -$3.4 million, up 25.69% from the prior year.
  • Profit After Tax for Q4 2024 stood at $1660259165.7 billion, up from -$2.1 million in the prior quarter.
  • The five-year high for Profit After Tax was $1660259165.7 billion in Q4 2024, with the low at -$2.1 million in Q4 2023.
  • The 5-year median for Profit After Tax is -$137081.9 (2023), against an average of $276709860.9 billion.
  • The sharpest annual moves came in 2022 and 2024: Profit After Tax slumped 14819.74% in 2022, then jumped 80082653894883.1% in 2024.
  • Immuron's Profit After Tax stood at -$57387.7 in 2020, then surged by 76.89% to -$13260.2 in 2021, then plunged by 14819.74% to -$2.0 million in 2022, then retreated by 4.79% to -$2.1 million in 2023, then surged by 80082653894883.1% to $1660259165.7 billion in 2024.
  • Business Quant data shows IMRN's Profit After Tax at $1660259165.7 billion in Q4 2024, -$2.1 million in Q4 2023, and -$216776.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Immuron 6.75 Mn 6.73 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,660,259,165.67 Bn
Dec 31, 2023 -2.07 Mn
Jun 30, 2023 -216,776.03
Dec 31, 2022 -1.98 Mn
Dec 31, 2021 -13,260.17
Dec 31, 2020 -57,387.72
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 -1.47 Mn
Sep 28, 2017 -4.76 Mn
Dec 31, 2016 -2.57 Mn
Jun 30, 2016 -3.28 Mn